Cassava's drug is a gene therapy and Aduhelm is targeting the amyloid plaque. The other big thing here is that Aduhelm is administered by IV ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fool.com/investing/2021/08/12/cassava-sciences-vs-biogen/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEWYBkzyvOyZubM8f0bpyUAySOi3A
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.